Skip to search formSkip to main contentSkip to account menu

WR279396

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
ABSTRACT Topical therapy is an attractive approach for the treatment of Leishmaniamajor cutaneous leishmaniasis (CL). WR279396… 
Highly Cited
2007
Highly Cited
2007
Background Because topical therapy is easy and usually painless, it is an attractive first-line option for the treatment of… 
Highly Cited
2002
Highly Cited
2002
We studied the efficacy of WR279396, a topical formulation of aminoglycosides that cures 100% of cutaneous leishmaniasis lesions… 
2002
2002
Abstract : Action was taken in three directions: 1) Coordination between sites. The French Study Coordinator visited the Tunisian… 
1995
1995
Abstract : This study evaluated the toxicity of WR279396 (Iowa Formulation 232 containing 15% paromomycin sulfate and 0.5…